Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

290
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
290
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

298
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
298
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

312
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
312
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

184
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
184
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

785
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
785
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

476
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
476

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The European Society of Pediatric Nephrology Board Examination-a certified benchmark of knowledge and clinical practice with global recognition.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Macroscopic hematuria in children with autosomal dominant polycystic kidney disease - report from four European tertiary centers.

European journal of pediatrics·2026
Same author

Diagnosis and management of mineral and bone disorders in paediatric kidney transplant recipients: a position statement from the European Society for Paediatric Nephrology.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Association between grade of congenital hydronephrosis and time to natural resolution.

Pediatric nephrology (Berlin, Germany)·2026
Same author

A case of nephrocalcinosis in a 7-month-old with congenital hypothyroidism: Insights from targeted exome sequencing.

Pediatric discovery..·2025
Same author

Primary renal diffuse large B-cell lymphoma presenting as new-onset kidney failure.

Pediatric nephrology (Berlin, Germany)·2025

Related Experiment Video

Updated: Jan 10, 2026

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

12.4K

Proteinuria After Kidney Transplantation.

Tomas Seeman1,2, Robert L Myette3,4, Janusz Feber2,3

  • 1Department of Pediatrics, Second Faculty of Medicine, Charles University, Prague, Czechia.

Pediatric Transplantation
|November 25, 2025
PubMed
Summary

Proteinuria is common after kidney transplants, affecting graft survival. Early detection and treatment of causes like rejection or FSGS recurrence are crucial for better outcomes.

Keywords:
angiotensin‐converting enzyme inhibitorsblood pressurechildrengraft survivalhypertensionkidney transplantationproteinuria

More Related Videos

Murine Renal Transplantation Procedure
18:48

Murine Renal Transplantation Procedure

Published on: July 10, 2009

30.5K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.8K

Related Experiment Videos

Last Updated: Jan 10, 2026

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

12.4K
Murine Renal Transplantation Procedure
18:48

Murine Renal Transplantation Procedure

Published on: July 10, 2009

30.5K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.8K

Area of Science:

  • Nephrology
  • Transplantation Immunology

Background:

  • Proteinuria is a frequent complication post-kidney transplant (40-80%) in adults and children.
  • It can be mild (tubular) or severe (glomerular), linked to rejection, mTOR inhibitors, hypertension, or FSGS recurrence.
  • Proteinuria significantly impacts graft and patient survival.

Purpose of the Study:

  • To highlight the importance of regular proteinuria assessment in pediatric kidney transplant recipients.
  • To emphasize prompt diagnosis and management of proteinuria causes, especially FSGS recurrence.
  • To outline therapeutic strategies and long-term goals for managing post-transplant proteinuria.

Main Methods:

  • Regular assessment of proteinuria using protein/creatinine ratio.
  • Daily monitoring in high-risk cases (e.g., idiopathic FSGS) during the early post-transplant period.
  • Diagnostic workup including graft biopsy if etiology is unclear.
  • Therapeutic interventions targeting identified causes, including ACE inhibitors and ARBs.

Main Results:

  • Proteinuria etiology varies, including rejection, mTOR inhibitors, hypertension, and FSGS recurrence.
  • Early detection of proteinuria aids in timely intervention.
  • Antiproteinuric therapy focuses on cause-specific treatment and blood pressure control.

Conclusions:

  • Regular proteinuria monitoring is essential for pediatric kidney transplant recipients.
  • Identifying and treating the underlying cause of proteinuria is key to improving graft survival.
  • Normalization of proteinuria (protein/creatinine ratio < 20 mg/mmol) is the long-term goal.